SABS ▼ -0.7% - SAB Biotherapeutics, Inc.
$SABS SABSW - SAB BIO Receives FDA Fast Track Designation for SAB-142 in Stage 3 Type 1 Diabetes
13-OCT-2026 08:30 AM ET
Share this post
More filings for $SABS
SABS ▲ +0.3% - SAB Biotherapeutics, Inc.Oct 1, 2026SABS ▲ +1.5% - SAB Biotherapeutics, Inc.Sep 22, 2026SABS - SAB Biotherapeutics, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 15, 2026SABS - SAB Biotherapeutics, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026SABS - SAB Biotherapeutics, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026SABS - SAB Biotherapeutics, Inc. - SEC Filing Update (12-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 12, 2026
View full $SABS filing history →💬 Comments
Loading comments…
Leave a comment